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Available online 20 January 2016Clobazam, a 1,5-benzodiazepine FDA-approved in 2011, is commonly used to treat anxiety and epilepsy. It has
not been associated with hypothermia until very recently, in a case report involving two pediatric patients.
Here, we report the ﬁrst case of hypothermia development in an adult patient with epilepsy associated with
clobazam use. A couple months after starting clobazam, the patient started developing episodes of hypothermia
every severalweeks, with temperatures ranging from90 °F–95 °F. Normothermiawas achievedwith Bair Hugger
therapy. Thyroid-stimulating hormone and cortisol levelswere normal, and therewas no evidence of infection in
most instances. After 11 total episodes of hypothermia over a year of clobazam use, the drugwas discontinued. It
has now been 7 months after discontinuation, and the patient has not experienced any more episodes of hypo-
thermia. Early recognition of the link between clobazamand hypothermiamay prevent avoidable EmergencyDe-
partment visits and hospitalizations.







Clobazam is a 1,5-benzodiazepine that has been used to treat anxiety
and epilepsy since the 1970s [1]. It works by activating the GABAA
receptor, increasing the frequency of chloride channel opening [2].
Although clobazam is only approved for Lennox–Gastaut syndrome in
the USA, it is regularly prescribed as an adjunctive therapy for refractory
epilepsy [1]. Clobazam usually has only mild side effects such as seda-
tion, dizziness, and ataxia [3]. However, a recent case report linked
clobazam to the development of hypothermia in two pediatric patients
[4]. Here, we describe the novel ﬁnding of hypothermia associated with
clobazam use in an adult patient.2. Case report
A 58-year-old male with severe developmental delay, convulsive
seizure disorder since the age of three, left hemiparesis, recurrent
aspiration pneumonia, and urinary retention presented for evaluation
of hypothermia. Over the preceding year, he had experienced nine
hypothermic episodes, with temperatures ranging from 90 °F–95 °F
(Fig. 1). The hypothermia was usually thought to be secondary to infec-
tion. Upon presentation, his temperature was 92 °F at his group home
and 95 °F in the ofﬁce.ilepsy Center, Department of
Haven, CT 06520-8018, United
hier), Imran.quraishi@yale.edu
. This is an open access article underThe patient, who was noncommunicative at baseline, was hospital-
ized and on examination appeared awake with no distress, calmly sit-
ting in his wheelchair. He is normally hyperactive, but his caregivers
noticed he would become listless during his hypothermic episodes.
His blood pressure was 138/74 mmHg, pulse was 59 beats per minute,
and oxygen saturation was 96%. The patient's lungs were clear to aus-
cultation, andhis heartbeat had a normal rate and rhythm,with nomur-
murs. He had full visual ﬁelds, intact extraocular movements, no
nystagmus, pupils equal and reactive to light, and a midline tongue.
He also had a left facial droop, increased spastic tone in the left arm
and leg, and intact reﬂexes, but sensation and strength could not be
tested.
Bair Hugger therapy, a forced air warming blanket, successfully
raised the patient's temperature to 97 °F, which was maintained after
it was removed. Empiric cephalexin and ciproﬂoxacin were started to
treat any potential infectious etiology of temperature dysregulation.
However, a urinalysis and chest X-ray were both unremarkable, and
cultures remained negative, so antibiotics were discontinued on hospi-
tal day two. TSH and cortisol levels were normal.
Additional past medical history included hyponatremia, hyperten-
sion, cyclothymia, renal cell carcinoma, iron deﬁciency, thrombocytope-
nia, osteoporosis, and gastroesophageal reﬂux disease. The patient was
taking phenytoin (200 mg/day), levetiracetam (3000 mg/day), and
clobazam (10 mg bid) for seizures, amlodipine (10 mg/day) for hyper-
tension, quetiapine (100mg/day) and ﬂuoxetine (30mg/day) for cyclo-
thymia, clonazepam (1 mg/day) for behavior, and aspirin (81 mg/day).
He had previously taken oxcarbazepine for epilepsy but switched to
clobazam because of hyponatremia. Clobazam had been started one
year prior, and it was the last drug added. Because of this and the factthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Episodes of hypothermia during clobazamuse. Thepatient experienced 11 total episodes of hypothermiaduring one year of clobazamuse, resulting inmany EmergencyDepartment
visits and a couple hospitalizations. There were no hypothermic episodes before clobazam use, and there have not been any after its discontinuation for 7 months. The horizontal line
represents the patient's average temperature.
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was tapered from 10 to 5 mg bid over one week. During this period,
the patient experienced one more hypothermic episode. Clobazam
was then discontinued after this week, and since then, there have
been no episodes of hypothermia for over half a year.
3. Discussion
This report describes an adult patient taking clobazam who experi-
enced multiple episodes of hypothermia, which stopped after the drug
was discontinued. Many patient populations are predisposed to devel-
oping hypothermia, including the young, the old, the mentally or phys-
ically disabled, and those taking certainmedications [5]. Our patient had
some of these risk factors. However, hypothermia occurred soon after
clobazam was initiated and stopped immediately after the drug's dis-
continuation, leading us to conclude that clobazam played a primary
role in the temperature dysregulation.
Benzodiazepines have been known to cause hypothermia through
central thermoregulatory failure [5]. Normally, cooling of the peripheral
circulation stimulates cold receptor afferents and the preoptic nucleus,
triggering vasoconstriction, shivering, and other responses to conserve
heat [5]. Tonic GABAergic signals inhibit the preoptic nucleus,
preventing it from excessively raising body temperature [6]. If this
tonic activity is increased, it could lower the set point temperature.
Clobazam and other benzodiazepines allosterically activate GABAA re-
ceptors, potentially causing this response [1]. There are many otherpossible mechanisms of clobazam-induced hypothermia [4]. Although
the exact mechanism remains unknown, future studies of patients
with less comorbidities and known serum drug levels could further in-
vestigate this association.
Regardless of the mechanism, early recognition of the link between
clobazam and hypothermia could allow for rapid reversal of the prob-
lem, preventing unnecessary visits and hospitalizations.Conﬂict of interest
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